Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans

Abstract Background Alzheimer’s disease (AD) is a major neurodegenerative disorder with significant environmental factors, including diet and lifestyle, influencing its onset and progression. Although previous studies have suggested that certain diets may reduce the incidence of AD, the underlying m...

Full description

Saved in:
Bibliographic Details
Main Authors: Bryan J. Neth, Kevin Huynh, Corey Giles, Tingting Wang, Natalie A. Mellett, Thy Duong, Colette Blach, Leyla Schimmel, Thomas C. Register, Kaj Blennow, Henrik Zetterberg, Richa Batra, Annalise Schweickart, Amanda Hazel Dilmore, Cameron Martino, Matthias Arnold, Jan Krumsiek, Xianlin Han, Pieter C. Dorrestein, Rob Knight, Peter J. Meikle, Suzanne Craft, Rima Kaddurah-Daouk
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-024-00682-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544338712035328
author Bryan J. Neth
Kevin Huynh
Corey Giles
Tingting Wang
Natalie A. Mellett
Thy Duong
Colette Blach
Leyla Schimmel
Thomas C. Register
Kaj Blennow
Henrik Zetterberg
Richa Batra
Annalise Schweickart
Amanda Hazel Dilmore
Cameron Martino
Matthias Arnold
Jan Krumsiek
Xianlin Han
Pieter C. Dorrestein
Rob Knight
Peter J. Meikle
Suzanne Craft
Rima Kaddurah-Daouk
author_facet Bryan J. Neth
Kevin Huynh
Corey Giles
Tingting Wang
Natalie A. Mellett
Thy Duong
Colette Blach
Leyla Schimmel
Thomas C. Register
Kaj Blennow
Henrik Zetterberg
Richa Batra
Annalise Schweickart
Amanda Hazel Dilmore
Cameron Martino
Matthias Arnold
Jan Krumsiek
Xianlin Han
Pieter C. Dorrestein
Rob Knight
Peter J. Meikle
Suzanne Craft
Rima Kaddurah-Daouk
author_sort Bryan J. Neth
collection DOAJ
description Abstract Background Alzheimer’s disease (AD) is a major neurodegenerative disorder with significant environmental factors, including diet and lifestyle, influencing its onset and progression. Although previous studies have suggested that certain diets may reduce the incidence of AD, the underlying mechanisms remain unclear. Method In this post-hoc analysis of a randomized crossover study of 20 elderly adults, we investigated the effects of a modified Mediterranean ketogenic diet (MMKD) on the plasma lipidome in the context of AD biomarkers, analyzing 784 lipid species across 47 classes using a targeted lipidomics platform. Results Here we identified substantial changes in response to MMKD intervention, aside from metabolic changes associated with a ketogenic diet, we identified a a global elevation across all plasmanyl and plasmenyl ether lipid species, with many changes linked to clinical and biochemical markers of AD. We further validated our findings by leveraging our prior clinical studies into lipid related changeswith AD (n = 1912), and found that the lipidomic signature with MMKD was inversely associated with the lipidomic signature of prevalent and incident AD. Conclusions Intervention with a MMKD was able to alter the plasma lipidome in ways that contrast with AD-associated patterns. Given its low risk and cost, MMKD could be a promising approach for prevention or early symptomatic treatment of AD.
format Article
id doaj-art-1d683ff91c3b4ab8869f7b492b29745e
institution Kabale University
issn 2730-664X
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Communications Medicine
spelling doaj-art-1d683ff91c3b4ab8869f7b492b29745e2025-01-12T12:37:15ZengNature PortfolioCommunications Medicine2730-664X2025-01-015111510.1038/s43856-024-00682-wConsuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humansBryan J. Neth0Kevin Huynh1Corey Giles2Tingting Wang3Natalie A. Mellett4Thy Duong5Colette Blach6Leyla Schimmel7Thomas C. Register8Kaj Blennow9Henrik Zetterberg10Richa Batra11Annalise Schweickart12Amanda Hazel Dilmore13Cameron Martino14Matthias Arnold15Jan Krumsiek16Xianlin Han17Pieter C. Dorrestein18Rob Knight19Peter J. Meikle20Suzanne Craft21Rima Kaddurah-Daouk22Department of Neurology, Mayo ClinicBaker Heart and Diabetes Institute, 75 Commercial RoadBaker Heart and Diabetes Institute, 75 Commercial RoadBaker Heart and Diabetes Institute, 75 Commercial RoadBaker Heart and Diabetes Institute, 75 Commercial RoadBaker Heart and Diabetes Institute, 75 Commercial RoadDuke Molecular Physiology Institute, Duke UniversityDepartment of Psychiatry and Behavioral Sciences, Duke UniversityDepartment of Pathology – Comparative Medicine, Wake Forest University School of MedicineDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of GothenburgDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of GothenburgDepartment of Physiology and Biophysics, Institute for Computational Biomedicine, Englander Institute for Precision Medicine, Weill Cornell MedicineDepartment of Physiology and Biophysics, Institute for Computational Biomedicine, Englander Institute for Precision Medicine, Weill Cornell MedicineDepartment of Pediatrics, University of California San DiegoDepartment of Pediatrics, University of California San DiegoDepartment of Psychiatry and Behavioral Sciences, Duke UniversityDepartment of Physiology and Biophysics, Institute for Computational Biomedicine, Englander Institute for Precision Medicine, Weill Cornell MedicineBarshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San AntonioSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San DiegoDepartments of Pediatrics, Computer Science and Engineering, Bioengineering, University of California San DiegoBaker Heart and Diabetes Institute, 75 Commercial RoadDepartment of Gerontology and Geriatric Medicine, Wake Forest University School of MedicineDepartment of Psychiatry and Behavioral Sciences, Duke UniversityAbstract Background Alzheimer’s disease (AD) is a major neurodegenerative disorder with significant environmental factors, including diet and lifestyle, influencing its onset and progression. Although previous studies have suggested that certain diets may reduce the incidence of AD, the underlying mechanisms remain unclear. Method In this post-hoc analysis of a randomized crossover study of 20 elderly adults, we investigated the effects of a modified Mediterranean ketogenic diet (MMKD) on the plasma lipidome in the context of AD biomarkers, analyzing 784 lipid species across 47 classes using a targeted lipidomics platform. Results Here we identified substantial changes in response to MMKD intervention, aside from metabolic changes associated with a ketogenic diet, we identified a a global elevation across all plasmanyl and plasmenyl ether lipid species, with many changes linked to clinical and biochemical markers of AD. We further validated our findings by leveraging our prior clinical studies into lipid related changeswith AD (n = 1912), and found that the lipidomic signature with MMKD was inversely associated with the lipidomic signature of prevalent and incident AD. Conclusions Intervention with a MMKD was able to alter the plasma lipidome in ways that contrast with AD-associated patterns. Given its low risk and cost, MMKD could be a promising approach for prevention or early symptomatic treatment of AD.https://doi.org/10.1038/s43856-024-00682-w
spellingShingle Bryan J. Neth
Kevin Huynh
Corey Giles
Tingting Wang
Natalie A. Mellett
Thy Duong
Colette Blach
Leyla Schimmel
Thomas C. Register
Kaj Blennow
Henrik Zetterberg
Richa Batra
Annalise Schweickart
Amanda Hazel Dilmore
Cameron Martino
Matthias Arnold
Jan Krumsiek
Xianlin Han
Pieter C. Dorrestein
Rob Knight
Peter J. Meikle
Suzanne Craft
Rima Kaddurah-Daouk
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
Communications Medicine
title Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
title_full Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
title_fullStr Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
title_full_unstemmed Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
title_short Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer’s disease in humans
title_sort consuming a modified mediterranean ketogenic diet reverses the peripheral lipid signature of alzheimer s disease in humans
url https://doi.org/10.1038/s43856-024-00682-w
work_keys_str_mv AT bryanjneth consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT kevinhuynh consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT coreygiles consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT tingtingwang consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT natalieamellett consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT thyduong consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT coletteblach consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT leylaschimmel consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT thomascregister consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT kajblennow consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT henrikzetterberg consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT richabatra consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT annaliseschweickart consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT amandahazeldilmore consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT cameronmartino consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT matthiasarnold consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT jankrumsiek consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT xianlinhan consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT pietercdorrestein consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT robknight consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT peterjmeikle consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT suzannecraft consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans
AT rimakaddurahdaouk consumingamodifiedmediterraneanketogenicdietreversestheperipherallipidsignatureofalzheimersdiseaseinhumans